Windlas Biotech consolidated net profit rises 11.68% in the June 2024 quarter

Net profit of Windlas Biotech rose 11.68% to Rs 13.48 crore in the quarter ended June 2024 as against Rs 12.07 crore during the previous quarter ended June 2023. Sales rose 20.97% to Rs 175.15 crore in the quarter ended June 2024 as against Rs 144.79 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	175.15	144.79	21
OPM %	11.92	11.84	-
PBDT	24.52	19.53	26
PBT	18.31	16.34	12
NP	13.48	12.07	12